Drugs / Autologous Adipose Mesenchymal Stem Cell
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04876326 Comparator | Oct 2020 → Oct 2021 | multiple system atrophy, parkinsonian type | Indonesia University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Adipose Mesenchymal Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04876326 ↗ |
| Route | Intrathecal | “Group 1 will receives MSC-Adipose Autologous with doses 2x50 million cells intratechally.” NCT04876326 ↗ |